Pfizer collaborates with Arvinas for breast cancer treatment ARV-471
ARV-471 is currently in Phase 2 studies for the treatment of patients with locally advanced or metastatic ER+/HER2-…
Novartis to pay $178m to Plexxikon over patent infringement case
23 Jul 21The jury found that the Novartis failed to prove that patents were invalid and concluded that the infringement…
Biovac teams up with Pfizer and BioNTech to produce Covid-19 vaccine in Africa
22 Jul 21Pfizer and BioNTech will immediately start technical transfer, on-site development and equipment installation activities
AstraZeneca completes $39bn acquisition of Alexion Pharmaceuticals
22 Jul 21With the acquisition, AstraZeneca now has an enhanced presence in rare diseases and immunology fields, using Alexion’s complement-biology…
Octapharma gets FDA nod for Octagam 10% to treat adult dermatomyositis
21 Jul 21The US FDA approval of Octagam is based on positive data from the Phase 3 ProDERM Study in…
Ronapreve approved in Japan to treat mild to moderate Covid-19
21 Jul 21The MHLW approval is based on a global Phase 3 trial which found Ronapreve reduced 70% hospitalisation or…
FDA approves Sanofi’s all-oral treatment for sleeping sickness
20 Jul 21Sanofi has developed the drug under the partnership with DNDi, and the National Sleeping Sickness Programmes of the…
US states to reveal $26bn opioid settlement with J&J, others
20 Jul 21Drug distributors McKesson, Cardinal Health and AmerisourceBergen would jointly pay $21bn, while J&J alone would pay $5bn
Merck gets US FDA approval for Vaxneuvance to prevent IPD
19 Jul 21Vaxneuvance triggered superior immune responses for serotypes 3, 22F and 33F compared to Merck’s 13-valent pneumococcal vaccine PCV13
GSK plans for new biotechnology and life science campus in UK
19 Jul 21The company aims to secure up to £400m in new private investment and create up to 5,000 new…